New drug combo aims to boost lymphoma treatment
Disease control
Not yet recruiting
This study tests a new drug, epcoritamab, added to standard chemotherapy (R-CHOP) for people newly diagnosed with an aggressive form of B-cell lymphoma. The main goal is to check for a specific side effect called cytokine release syndrome. About 20 adults will take part in this e…
Phase: PHASE2 • Sponsor: Mwanasha Merrill, MD • Aim: Disease control
Last updated May 17, 2026 04:17 UTC